| 贝伐珠单抗在非小细胞肺癌中的应用进展 |
| |
| 引用本文： | 徐萍,李红梅. 贝伐珠单抗在非小细胞肺癌中的应用进展[J]. 中国肺癌杂志, 2017, 0(4): 272-277. DOI: 10.3779/j.issn.1009-3419.2017.04.08 |
| |
| 作者姓名： | 徐萍 李红梅 |
| |
| 作者单位： | 青岛大学附属医院肿瘤科,青岛,266000 |
| |
| 摘 要： | 目前非小细胞肺癌已是世界上发病率最高的癌症之一,且其发病率在逐年增加,这种现状促使人们不断寻求各种治疗手段以期延长患者的生存期,改善患者的生活质量.本综述旨在通过迄今为止有关临床数据,全面讨论贝伐珠单抗在治疗非小细胞肺癌中的应用进展,探讨该药物在临床使用中可能出现的问题、患者的更有效选择以及未来的发展方向.
|
| 关 键 词： | 贝伐珠单抗 肺肿瘤 不良反应 |
Application of Bevacizumab in Non-small Cell Lung Cancer |
| |
| Ping XU,Hongmei LI. Application of Bevacizumab in Non-small Cell Lung Cancer[J]. Chinese journal of lung cancer, 2017, 0(4): 272-277. DOI: 10.3779/j.issn.1009-3419.2017.04.08 |
| |
| Authors: | Ping XU Hongmei LI |
| |
| Abstract: | At present,non-small cell lung cancer is one of the highest incidence of cancers in the world,and its incidence increased year by year,this situation prompted people to continue to seek a variety of treatment in order to extend the survival of patients and improve the quality of life of patients.This review aims to discuss the progress ofbevacizumab in the treatment of non-small cell lung cancer,through the clinical data so far to explore the clinical use of the drug,the choice of patients and the future direction of development. |
| |
| Keywords: | Bevacizumab Lung neoplasms Adverse events |
| 本文献已被 万方数据 等数据库收录！ |
|
